These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 11050782)
21. Secondary prevention in coronary heart disease. Effects of statins have been in addition to those of aspirin and beta blockers. Morrell J BMJ; 1999 May; 318(7195):1419-20. PubMed ID: 10334767 [No Abstract] [Full Text] [Related]
22. Lipid-lowering drug therapy in elderly patients. Berthold HK; Gouni-Berthold I Curr Pharm Des; 2011; 17(9):877-93. PubMed ID: 21418034 [TBL] [Abstract][Full Text] [Related]
23. Statins for stroke: the second story? Plutzky J; Ridker PM Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683 [No Abstract] [Full Text] [Related]
24. Statins: is there a need for alternative or adjunctive therapy? Shepherd J Br Heart J; 1995 Jul; 74(1):13. PubMed ID: 7662445 [No Abstract] [Full Text] [Related]
25. DoH explains thinking behind national service framework for coronary heart disease. Boyle R BMJ; 2000 Oct; 321(7268):1083. PubMed ID: 11053200 [No Abstract] [Full Text] [Related]
26. A tale of two trials: The West of Scotland Coronary Prevention Study and the Texas Coronary Atherosclerosis Prevention Study. Shepherd J Atherosclerosis; 1998 Aug; 139(2):223-9. PubMed ID: 9712327 [TBL] [Abstract][Full Text] [Related]
27. Lipid-lowering therapy for elderly patients at risk for coronary events and stroke. Courville KA; Lavie CJ; Milani RV Am Heart Hosp J; 2005; 3(4):256-62. PubMed ID: 16330918 [TBL] [Abstract][Full Text] [Related]
28. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations. Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212 [No Abstract] [Full Text] [Related]
29. New British recommendations for prevention of coronary heart disease in clinical practice. Faergeman O Heart; 1999 Apr; 81(4):335. PubMed ID: 10092555 [No Abstract] [Full Text] [Related]
30. New evidence, new guidelines. Shepherd J Atherosclerosis; 1998 Oct; 140(2):197-8. PubMed ID: 9862268 [No Abstract] [Full Text] [Related]
31. Beyond statins: what to expect from add-on lipid regulating therapy? Laufs U; Weintraub WS; Packard CJ Eur Heart J; 2013 Sep; 34(34):2660-5. PubMed ID: 23832488 [No Abstract] [Full Text] [Related]
32. The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes. Karalis DG Clin Cardiol; 2008 Jun; 31(6):241-8. PubMed ID: 17847038 [TBL] [Abstract][Full Text] [Related]